Related Experiment Video
Updated: Aug 7, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
HFE mutations in idiopathic dilated cardiomyopathy
Andreas Erhardt1, Claudia Mellenthin, Christian Perings
1Department of Gastroenterology, Hepatology and Infectiology, Heinrich Heine University Duesseldorf, Germany. Erhardt@uni-duesseldorf.de
Mutations in the hemochromatosis (HFE) gene were more common in patients with idiopathic dilated cardiomyopathy (IDCM). Screening IDCM patients for iron parameters is recommended due to increased HFE gene mutations.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Dilated cardiomyopathy (DCM) is a known complication of hereditary hemochromatosis (HH).
- The role of hemochromatosis (HFE) gene mutations in idiopathic dilated cardiomyopathy (IDCM) requires further investigation.
Purpose of the Study:
- To determine if HFE gene mutations are a cause or modifying factor in IDCM.
- To assess the prevalence of HFE mutations in IDCM patients compared to healthy controls.
Main Methods:
- Genetic analysis of the HFE gene in 46 IDCM patients and 350 controls.
- Clinical and biochemical assessments of all participants.
- Cardiomyopathy diagnosis based on established angiographic criteria.
Main Results:
- C282Y homozygosity was significantly higher in IDCM patients (4.3%) than controls (0.6%).
- 6.5% of IDCM patients had disease-predisposing HFE genotypes (C282Y homozygotes or compound heterozygotes).
- No significant differences in cardiac function or iron levels were observed between HFE carriers and non-carriers.
Conclusions:
- Increased prevalence of disease-predisposing HFE gene mutations in IDCM suggests a potential link.
- Screening IDCM patients for iron parameters is warranted.
- The exact contribution of iron or immune factors to IDCM pathogenesis remains uncertain.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

